← Leaderboards
Karla Gabriela Cano Hernandez
Ut Southwestern Medical Center
$89,791
Attributed
$89,791
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36.9K · FY2022–24$50K$37.5K$25K$12.5K$0
'22
'23
'24
Funding mix
By agency
NIH$89,791 · 1
By mechanism
F31$89,791 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Kim Orth$8,651,385
- Anju Sreelatha$1,297,461
- Thomas J Wang$21,119,622
- Rene L Galindo$2,308,569
- Joseph A. Hill$28,732,318
Others in their field
Other Rising Stars on “Enzymes”
- Jason Dickens · Duke University$12,259,409
- John Alam · Eip Pharma, Inc.$10,411,018
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Kenneth Schultz · Trethera Corporation$8,384,949
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
- Jennifer Wierman · Cornell University$7,750,000
Research focus
Enzymes5&AposAdora2a GeneAdenosineAdenosine MonophosphateAkt Signaling PathwayBalanced Chromosomal TranslocationBindingAffectBlocking FactorCategoriesAgonistCell GrowthCellsCell Surface ProteinsChemotherapy And/Or RadiationChildhood Soft Tissue SarcomaChimeric ProteinsChip-SeqBinding SitesDisease-Free SurvivalDoxycyclineDriver MutationEvent
Grant awards (3)
The Molecular function of ecto 5' nucleotidase in fusion-negative rhabdomyosarcoma$17,276
F31 · FY2024 · CA · contact PI
The Molecular function of ecto 5' nucleotidase in fusion-negative rhabdomyosarcoma$36,851
F31 · FY2023 · CA · contact PI
The Molecular function of ecto 5' nucleotidase in fusion-negative rhabdomyosarcoma$35,664
F31 · FY2022 · CA · contact PI